LAWRENCEVILLE, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated...
CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
CARLSBAD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing...
FDA briefing included new Ewing sarcoma clinical data from ongoing investigation where 60% of first-relapse patients achieved disease control and...
– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025...
BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable...
PGX processing unit with a 10X (100 L) vessel capacity to be installed and tested at NATEX pilot testing facility...
Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the...
Denver, Colorado--(Newsfile Corp. - November 7, 2023) - Last week, the CBD of Denver, Inc.'s (OTC Pink: CBDD), Luxora team...
Oakville, Ontario--(Newsfile Corp. - November 7, 2023) - FendX Technologies Inc. (CSE:FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX")...
Scientist, inventor, business expert, and holder of more than 140 patents will bring forward PUR Biologics' regenerative therapeutic patent portfolio...
DUBLIN, IRELAND / ACCESSWIRE / November 7, 2023 / Nemysis is pleased to announce receipt of grant funding under the...
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or...
GOTHENBURG, SE / ACCESSWIRE / November 07, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, November 7, 2023 - IRLAB...